01 1PolyPeptide Group
01 1LIRAGLUTIDE
01 1Switzerland
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-09-29
Pay. Date : 2021-07-15
DMF Number : 35860
Submission : 2021-06-24
Status : Active
Type : II
20
Polypeptide Laboratories Inc, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LIRAGLUTIDE, with a corresponding US DMF Number 35860.
Remarkably, this DMF maintains an Active status since its submission on June 24, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 29, 2021, and payment made on July 15, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
